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Introduction:
In general, the diagnosis of Parkinson's disease (PD) is dependent on the identi cation of motor symptoms
benchmarked by a loss of 50% of nigrostriatal neurons. This strongly motivates the de nition of biomarkers to
detect PD at the earliest pre-clinical stages. Morphological brain differences between PD and healthy controls
(HC) can potentially reveal key regions affected during the PD prodromal phase. Voxel-based morphometry (VBM)
is a popular automatic technique allowing the detection of subtle morphometric group differences at a voxel level
in structural MRI.
Methods:
We performed a VBM study of 144 de novo PD patients (age: 61.30y±9.06; sex: 53F) and 66 HC (age:
60.12y±11.39; sex: 23F) from the PPMI database [1] through two different state-of-the-art pipelines: 1) CAT12 [2]
and 2) volBrain [3]. All 3D T1-weighted scans selected were obtained under the same acquisition conditions. Both
CAT12 and volBrain follow similar pre-processing steps including intensity normalization, bias and noise
correction. CAT12 registers the images to a reference brain using an af ne and non-linear method, whereas
volBrain utilizes a linear af ne transformation. For tissue segmentation, CAT12 integrates a classical Markov
Random Field and the Adaptive Maximum Posterior (AMAP) technique to reduce the dependency on tissue
probability maps. In addition, partial volumes are estimated using two additional mixed classes: GM-WM and GM-
CSF. volBrain robustly computes the mean values of the different tissues by excluding partial volume voxels and
using an unbiased robust mean estimator [3]. Partial volume coef cients are computed as well. volBrain segments
the brain into cerebrum, cerebellum, brainstem, hemispheres and seven subcortical structures (putamen, caudate,
globus pallidus, thalamus, hippocampus, amygdala, and accumbens) with a multi-template method that considers a
non-local label fusion scheme [4]. Additionally substantia nigra was manually delineated. The segmented images
from both pipelines (Fig 1) were modulated and smoothed with an isotropic Gaussian kernel (8mm). The statistical
analysis was performed with CAT12. We designed a general linear model (GLM) where age, sex, and total
intracranial volumes (TIV) were used as covariates and compared GM and WM maps of PD vs HC with a two-
sample T-test. To equilibrate size populations [5], we repeated our analysis  ve times with 66 controls versus 66
randomly selected patients using sampling with replacement technique.
Results:
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For the differential analysis, PD vs HC, no voxels survive (p<0.05 FWE corr.) for neither CAT12 or volBrain tissue
images. We also analyzed independently the subcortical structures segmented by volBrain, previously deformed
to CAT12 template space with DARTEL. No differences were found (p<0.05 FWE corr.). Exploratory analysis
(p<0.001 uncorr.) revealed decreases in caudate nucleus, hippocampus, putamen and substantia nigra (manually
segmented). No differences were found (p<0.05 FWE corr.) in the equilibrated populations.
Conclusions:
Using two recent approaches for accurate tissue classi cation (CAT12 and volBrain) we failed to detect robust
structural differences between de novo PD patients and healthy controls. Findings of structural brain differences
reported in the literature tend to be contradictory. This lack of consensus may be due to a variety of factors,
notably the study of small cohorts, differences in segmentation techniques, and more importantly, the lack of
correction for multiple comparison inevitably increasing false positive rates. We reinforce the message that VBM
is a delicate technique involving many parameters that should be handled with care to avoid false positive
impacting the  nal results [5]. In sight of the lack of morphological differences, we suspect that early PD
biomarkers may lie on the physiological properties of the Parkinsonian brain and could be investigated through
quantitative MRI techniques (relaxometry, diffusion and perfusion imaging).
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   ·volBrain segmentation: a) GM, b) WM and c) subcortical structures. d) Manually segmented substantia nigra.
 
